Biomimetic Immunoregulators for the Multi-Target Inflammation Interruption in Autoimmune Diseases
ACS Nano · 05.08.2025 · 19 (30) · 27294-27309
DOI: 10.1021/acsnano.5c04655 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 23.07.2025. Verfasst von Zhongmin Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Institute of Functional Nano & Soft Materials (FUNSOM), Collaborative Innov…. Hauptthemen laut MEDLINE: Cerium, Biomimetic Materials, Autoimmune Diseases, Inflammation. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China, Higher Education Discipline Innovation Project.
Abstract (Originalsprache)
Cell-free DNA (cfDNA), reactive oxygen species (ROS), and pro-inflammatory cytokines interplay to form a self-amplified inflammatory cascade in autoimmune diseases (AIDs), accounting for the limited efficacy of single-target therapeutic modalities. Herein, biomimetic nanoparticles (NPs), constructed from macrophage membrane (RM)-coated cerium oxide (CeO2), are developed to concurrently scavenge multiple inflammatory mediators for AID management. Upon systemic administration, the NPs feature long blood circulation and targeted accumulation at the inflamed site. In the inflammatory microenvironment, RM with abundant cytokine receptors neutralizes varieties of pro-inflammatory cytokines, and CeO2 with nuclease- and antioxidase-like activities scavenges multiple types of ROS. In addition, O2 bubbles generated from CeO2-catalyzed H2O2 decomposition foster membrane shedding and subsequent CeO2 exposure for effective cfDNA cleavage. Thus, the NPs effectively interrupt the inflammatory cycle and promote tissue repair in mouse models of AIDs including rheumatoid arthritis and autoimmune hepatitis. This study provides an effective mechanism for the multi-target management of inflammation, which holds profound implications for the treatment of AIDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Institute of Functional Nano & Soft Materials (FUNSOM), Collaborative Innovation Center of Suzhou Nano Science & Technology, Soochow University,…
- Department of Gastroenterology, The Second Affiliated Hospital, Soochow University, Suzhou 215004, China.
ORCID-Profile: Jing Yan, Duanmin Hu, Lichen Yin
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China
- Higher Education Discipline Innovation Project
- Collaborative Innovation Center of Suzhou Nano Science & Technology
- Joint International Research Laboratory of CarbonBased Functional Materials and Devices
- Suzhou Key Laboratory of Nanotechnology and Biomedicine
Zitieren
APA
Liu, Z., Yan, J., Zhou, Y., Yin, M., Zhou, R., Shen, J., Hu, D., & Yin, L. (2025). Biomimetic Immunoregulators for the Multi-Target Inflammation Interruption in Autoimmune Diseases. ACS Nano, 19(30), 27294-27309. https://doi.org/10.1021/acsnano.5c04655
Vancouver
Liu Z, Yan J, Zhou Y, Yin M, Zhou R, Shen J, et al. Biomimetic Immunoregulators for the Multi-Target Inflammation Interruption in Autoimmune Diseases. ACS Nano. 2025;19(30):27294-27309. doi:10.1021/acsnano.5c04655
BibTeX
@article{Liu2025,
author = {Liu, Zhongmin and Yan, Jing and Zhou, Yang and Yin, Mengyuan and Zhou, Renxiang and Shen, Jingrui and Hu, Duanmin and Yin, Lichen},
title = {Biomimetic Immunoregulators for the Multi-Target Inflammation Interruption in Autoimmune Diseases},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {30},
pages = {27294--27309},
doi = {10.1021/acsnano.5c04655}
}
EUVIMED